Decoded
Decoded
Podcast Description
Decoded is the podcast hosted by Dr. Jurgi Camblong - Founder and CEO of SOPHiA GENETICS, molecular biologist, and global leader and pioneer of data-driven medicine.In each episode, he connects with world-class scientists, clinicians, innovators, and policymakers to uncover how data, technology, and clinical expertise converge to transform care.From accelerating cancer diagnostics to transforming the understanding of rare and inherited disorders, Decoded goes beyond the buzz to reveal how innovation translates into real outcomes for patients worldwide.With a sharp focus on multimodal data, AI in healthcare, and global equal access to patient care, Decoded goes beyond theory to decode what’s working - and what it takes to scale innovation that truly improves lives.
Podcast Insights
Content Themes
The podcast centers on topics such as multimodal data utilization, AI in healthcare, and equitable access to medical care, with specific episodes like 'Liquid Biopsy Decoded' exploring advancements in cancer diagnostics and discussions on the integration of molecular insights to personalize treatments and improve clinical outcomes.
Decoded is the podcast hosted by Dr. Jurgi Camblong – Founder and CEO of SOPHiA GENETICS, molecular biologist, and global leader and pioneer of data-driven medicine.
In each episode, he connects with world-class scientists, clinicians, innovators, and policymakers to uncover how data, technology, and clinical expertise converge to transform care.
From accelerating cancer diagnostics to transforming the understanding of rare and inherited disorders, Decoded goes beyond the buzz to reveal how innovation translates into real outcomes for patients worldwide.
With a sharp focus on multimodal data, AI in healthcare, and global equal access to patient care, Decoded goes beyond theory to decode what’s working – and what it takes to scale innovation that truly improves lives.
What happens when a world-class biologist decides that academic research isn't moving fast enough for patients?
Dr. Keith Flaherty is a physician, scientist, and founder who obsesses over the ”wiring of cells”. As the Director of Clinical Research at the Mass General Hospital Cancer Center and a Professor of Medicine at Harvard Medical School, he has authored over 300 peer-reviewed research publications. But he didn't stop at academia. He went on to co-found Loxo Oncology and Scorpion Therapeutics, driving billions in acquisitions and fundamentally changing precision cancer care.
In this episode, Keith joins Dr. Jurgi Camblong to discuss his journey from early cell biology to becoming president-elect of the AACR. They explore the evolution of melanoma treatments, the mechanics of targeted inhibitors, and the friction in the system that prevents us from learning from every patient.
Because better outcomes don’t come from better science alone. They come from making the whole system work.
#Oncology #PrecisionMedicine #AACR #DrugDevelopment #DecodedPodcast
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.